TrialEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences2017

A Phase I randomized clinical trial testing the safety, tolerability and preliminary pharmacokinetics of the mGluR5 negative allosteric modulator GET 73 following single and repeated doses in healthy volunteers.

Carolina L Haass-Koffler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.